Trial Profile
Intra-mammary Distribution of Transdermal Telapristone Versus Oral Telapristone: A Randomized Window Trial in Women Undergoing Mastectomy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Feb 2023
Price :
$35
*
At a glance
- Drugs Telapristone (Primary) ; Telapristone (Primary)
- Indications Carcinoma; Ductal carcinoma; Early breast cancer
- Focus Pharmacokinetics
- 26 Jan 2023 Status changed from discontinued to completed.
- 12 Oct 2020 Status changed from active, no longer recruiting to discontinued as per results published in the Clinical Pharmacology and Therapeutics.
- 30 Sep 2020 Results published in the Clinical Pharmacology and Therapeutics